Market Overview The Prostate Cancer Market is witnessing significant growth in systemic therapies for metastatic and advanced prostate cancer, driven by the increasing prevalence of castration-resistant disease and the development of novel therapeutic agents. Metastatic prostate cancer requires systemic treatment, including hormone therapy, chemotherapy, and novel targeted agents. The...